EUVIMEDOpdag EUVIMED
Crossref

Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility

Reem Darwesh,, Balsam Fahad Sofi, Nihal S. Elbialy, Jaber Hussain Alsalah

Engineered Science · 2026

DOI: 10.30919/es2173 ↗

At a glance

Journal article in Engineered Science, 2026. Written by Reem Darwesh, and 3 co-authors. Cited 1 times so far (Crossref).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Cite

APA

Darwesh,, R., Sofi, B. F., Elbialy, N. S., & Alsalah, J. H. (2026). Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility. Engineered Science. https://doi.org/10.30919/es2173

Vancouver

Darwesh, R, Sofi BF, Elbialy NS, Alsalah JH. Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility. Engineered Science. 2026. doi:10.30919/es2173

BibTeX
@article{Darwesh2026,
  author = {Darwesh,, Reem and Sofi, Balsam Fahad and Elbialy, Nihal S. and Alsalah, Jaber Hussain},
  title = {Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility},
  journal = {Engineered Science},
  year = {2026},
  doi = {10.30919/es2173}
}
Start for free →